Cargando…
Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039295/ https://www.ncbi.nlm.nih.gov/pubmed/35496305 http://dx.doi.org/10.3389/fphar.2022.896418 |
| _version_ | 1784694095385460736 |
|---|---|
| author | He, Xiao-Ming He, Min-Cong Yang, Peng Zhang, Qing-Wen Chen, Zhen-Qiu He, Wei Wei, Qiu-Shi |
| author_facet | He, Xiao-Ming He, Min-Cong Yang, Peng Zhang, Qing-Wen Chen, Zhen-Qiu He, Wei Wei, Qiu-Shi |
| author_sort | He, Xiao-Ming |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9039295 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90392952022-04-27 Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years He, Xiao-Ming He, Min-Cong Yang, Peng Zhang, Qing-Wen Chen, Zhen-Qiu He, Wei Wei, Qiu-Shi Front Pharmacol Pharmacology Frontiers Media S.A. 2022-04-12 /pmc/articles/PMC9039295/ /pubmed/35496305 http://dx.doi.org/10.3389/fphar.2022.896418 Text en Copyright © 2022 He, He, Yang, Zhang, Chen, He and Wei. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology He, Xiao-Ming He, Min-Cong Yang, Peng Zhang, Qing-Wen Chen, Zhen-Qiu He, Wei Wei, Qiu-Shi Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years |
| title | Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years |
| title_full | Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years |
| title_fullStr | Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years |
| title_full_unstemmed | Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years |
| title_short | Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years |
| title_sort | corrigendum: the therapeutic effect of huo xue tong luo capsules in association research circulation osseous (arco) stage ii osteonecrosis of the femoral head: a clinical study with an average follow-up period of 7.95 years |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039295/ https://www.ncbi.nlm.nih.gov/pubmed/35496305 http://dx.doi.org/10.3389/fphar.2022.896418 |
| work_keys_str_mv | AT hexiaoming corrigendumthetherapeuticeffectofhuoxuetongluocapsulesinassociationresearchcirculationosseousarcostageiiosteonecrosisofthefemoralheadaclinicalstudywithanaveragefollowupperiodof795years AT hemincong corrigendumthetherapeuticeffectofhuoxuetongluocapsulesinassociationresearchcirculationosseousarcostageiiosteonecrosisofthefemoralheadaclinicalstudywithanaveragefollowupperiodof795years AT yangpeng corrigendumthetherapeuticeffectofhuoxuetongluocapsulesinassociationresearchcirculationosseousarcostageiiosteonecrosisofthefemoralheadaclinicalstudywithanaveragefollowupperiodof795years AT zhangqingwen corrigendumthetherapeuticeffectofhuoxuetongluocapsulesinassociationresearchcirculationosseousarcostageiiosteonecrosisofthefemoralheadaclinicalstudywithanaveragefollowupperiodof795years AT chenzhenqiu corrigendumthetherapeuticeffectofhuoxuetongluocapsulesinassociationresearchcirculationosseousarcostageiiosteonecrosisofthefemoralheadaclinicalstudywithanaveragefollowupperiodof795years AT hewei corrigendumthetherapeuticeffectofhuoxuetongluocapsulesinassociationresearchcirculationosseousarcostageiiosteonecrosisofthefemoralheadaclinicalstudywithanaveragefollowupperiodof795years AT weiqiushi corrigendumthetherapeuticeffectofhuoxuetongluocapsulesinassociationresearchcirculationosseousarcostageiiosteonecrosisofthefemoralheadaclinicalstudywithanaveragefollowupperiodof795years |